A drug interaction study between ticlopidine and cyclosporin in heart transplant recipients

No abstract is available for this paper.

• Publication year

  1997

• Venue

  European Journal of Clinical Pharmacology

• Publication date

  Unknown publication date

• Fields of study

  Medicine

• Identifiers
  DOI 10.1007/s002280050334PMID 9349928
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• ADP receptors on platelets and ADP-selective antiaggregating agents.

  1996cited by this paper
• Effect of fenofibrates in heart transplant patients.

  1995cited by this paper
• Platelet aggregation and HDL cholesterol are predictive of acute coronary events in heart transplant recipients.

  1994cited by this paper
• The long-term effects of the lipid-lowering agent fenofibrate in hyperlipidemic heart transplant recipients.

  1994cited by this paper
• Evaluation of ticlopidine, a novel inhibitor of platelet aggregation, in heart transplant recipients.

  1993influential reference
• Platelet function and composition in heart transplant recipients compared with nontransplanted coronary patients.

  1992cited by this paper
• Pharmacokinetics of cyclosporine in hyperlipidaemic long-term survivors of heart transplantation

  1992cited by this paper
• Enzyme induction by drugs and toxins.

  1992cited by this paper
• A comparative study of cyclosporine vs FK 506: role of kidney microsomal cytochrome P-450.

  1992cited by this paper
• Management of Drug Interactions With Cyclosporine

  1991cited by this paper
• Single and multiple dose pharmacokinetics of ticlopidine in young and elderly subjects.

  1991influential reference
• The effect of meal composition on cyclosporine absorption.

  1991cited by this paper
• Recent Advances in Cyclosporine Pharmacokinetics

  1991cited by this paper
• Increased platelet aggregation after heart transplantation: influence of aspirin.

  1991cited by this paper
• Interaction of cyclosporin and ticlopidine.

  1991cited by this paper
• Eight-year results of cyclosporine-treated patients with cardiac transplants.

  1990cited by this paper
• Low-dose aspirin and accelerated coronary disease in heart transplant recipients.

  1990cited by this paper
• Cyclosporine.

  1989cited by this paper
• The increase in urinary excretion of 6 beta-hydroxycortisol as a marker of human hepatic cytochrome P450IIIA induction.

  1989cited by this paper
• Doppler echocardiography for the diagnosis of acute cardiac allograft rejection.

  1988cited by this paper
• Cyclosporine A enhances platelet aggregation.

  1987cited by this paper
• Development of coronary artery disease in cardiac transplant patients receiving immunosuppressive therapy with cyclosporine and prednisone.

  1987cited by this paper
• Ticlopidine‐theophylline interaction

  1987cited by this paper
• 6 beta-hydroxycortisol in serum and urine as determined by enzyme immunoassay on microtitre plates.

  1986cited by this paper
• Simplified liquid chromatographic analysis for cyclosporin A in blood and plasma with use of rapid extraction.

  1985cited by this paper
• Noninvasive Determination of Left Ventricular End‐systolic Stress: Validation of the Method and Initial Application

  1982cited by this paper

• Graph-augmented Convolutional Networks on Drug-Drug Interactions Prediction

  2019cites this paper
• A critical appraisal of the functional evolution of P2Y12 antagonists as antiplatelet drugs.

  2012cites this paper
• Is the interaction between ticlopidine and cyclosporin dose related? Report of three cases

  2010cites this paper
• Ticlopidine-induced hepatotoxicity is associated with specific human leukocyte antigen genomic subtypes in Japanese patients: a preliminary case–control study

  2008cites this paper
• HIGH VOLUME BIOASSAYS TO ASSESS CYP3A4-MEDIATED DRUG INTERACTIONS: INDUCTION AND INHIBITION IN A SINGLE CELL LINE

  2005cites this paper
• Drug therapy in the heart transplant recipient: part IV: drug-drug interactions.

  2005cites this paper
• Drug Therapy in the Heart Transplant Recipient

  2005cites this paper
• Drug therapy in the heart transplant recipient: part I: cardiac rejection and immunosuppressive drugs.

  2004cites this paper
• BIOASSAYS TO ASSESS CYP 3 A 4-MEDIATED DRUG INTERACTIONS : INDUCTION AND INHIBITION IN A SINGLE CELL LINE

  2004cites this paper
• Urinary 6β-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals

  2003cites this paper
• Urinary 6beta-hydroxycortisol: a validated test for evaluating drug induction or drug inhibition mediated through CYP3A in humans and in animals.

  2003cites this paper
• Treatment with Ticlopidine Is Associated with Reduction of Cyclosporin A Blood Levels

  2002cites this paper
• Drug Interaction between Ticlopidine and Cyclosporine

  2001cites this paper
• DEET ( N,N -DIETHYL- m -TOLUAMIDE) ALONE AND IN COMBINATION WITH PERMETHRIN INCREASED URINARY EXCRETION OF 6β-HYDROXYCORTISOL IN RATS, A MARKER OF HEPATIC CYP3A INDUCTION

  2001cites this paper
• In vitro inhibition of the cytochrome P450 (CYP450) system by the antiplatelet drug ticlopidine: potent effect on CYP2C19 and CYP2D6.

  2000cites this paper
• Drug points: Probable interaction between cyclosporin A and low dose ticlopidine

  2000cites this paper
• Rash in Patients Receiving Ticlopidine after Intracoronary Stent Placement

  1999cites this paper
• Ticlopidine increases nitric oxide generation in heart-transplant recipients: a possible novel property of ticlopidine.

  1998cites this paper
• The Antiplatelet Effects of Ticlopidine and Clopidogrel

  1998cites this paper